开始
slkc85

JNJ looks promising for a breakout

做多
Johnson & Johnson (NYSE:JNJ)  
slkc85  
NYSE:JNJ   Johnson & Johnson
Trend Analysis
0
0
trendanalysis
JNJ looks promising for a breakout. With MRNA vaccines facing increased scrutiny in Europe, JNJ may benefit potentially.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。